NCT02474810View on ClinicalTrials.gov

Intensive Versus Standard Hemodialysis CVC Dysfunction Protocol

NACompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

July 31, 2015

Study Completion Date

September 30, 2015

Conditions
Chronic Renal Insufficiency
Interventions
DRUG

Alteplase

Alteplase for CVC dysfunction.

Trial Locations (1)

b3h 2y9

Capital Health District Authority, Department of Medicine, Division of Nephrology, Halifax

All Listed Sponsors
lead

Nova Scotia Health Authority

OTHER

NCT02474810 - Intensive Versus Standard Hemodialysis CVC Dysfunction Protocol | Biotech Hunter | Biotech Hunter